Clinical trial
Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte…
NCT05935202 · EuroBloodNet Association, Other · Not yet recruiting
Key facts
| NCT number | NCT05935202 |
|---|---|
| Title | Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies |
| Official title | Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies |
| Acronym | SATISFY |
| Lead sponsor | EuroBloodNet Association, Other |
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hereditary Red Blood Cell Disorder (Disorder) |
| Intervention type | Drug |
| Interventions | Mitapivat sulfate |
| Enrollment | 25 |
| Start date | Dec 21, 2023 |
| Primary completion | Jul 15, 2025 |
| Completion | Dec 15, 2026 |
| First posted | Jul 7, 2023 |
| Last update posted | Dec 26, 2023 |
| Countries | Denmark, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: